• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与不同人β-微管蛋白亚型结合的卡巴他赛结合模式:DFT 和 MD 研究。

Binding modes of cabazitaxel with the different human β-tubulin isotypes: DFT and MD studies.

机构信息

School of Biomedical Engineering and Technology, Tianjin Medical University, 22 Qixiangtai Road, Tianjin, 300070, China.

Hefei National Laboratory of Physical Sciences at the Microscale, University of Science and Technology of China, Hefei, 230026, Anhui, China.

出版信息

J Mol Model. 2020 May 30;26(6):162. doi: 10.1007/s00894-020-04400-w.

DOI:10.1007/s00894-020-04400-w
PMID:32474655
Abstract

Taxanes (paclitaxel, docetaxel, cabazitaxel) are anticancer drugs as microtubule inhibitors. Following our previous studies on paclitaxel and docetaxel, in this work, we examine cabazitaxel and compare these three taxenes. The binding interaction of three taxanes with various β-tubulin isotypes is studied by homology modeling, molecular docking, and molecular dynamics simulations. The results show that the effects of docetaxel on βI-tubulin (- 29.5 kcal/mol) and of paclitaxel on βIIa-tubulin (- 25.5 kcal/mol) are much stronger than their effects on βIII-tubulin (- 17.8 kcal/mol and - 8.6 kcal/mol, respectively). However, the effect of cabazitaxel on βIII-tubulin (- 23.0 kcal/mol) is comparable with that on βI-tubulin (- 24.0 kcal/mol) and βIIa-tubulin (- 25.9 kcal/mol), consistent with the fact that overexpression of βIII-tubulin increases the drug resistance to paclitaxel and docetaxel, but has little influence for cabazitaxel. This theoretical research supports the use of cabazitaxel for patients who are resistant to the action of paclitaxel and docetaxel.

摘要

紫杉烷类(紫杉醇、多西他赛、卡巴他赛)是作为微管抑制剂的抗癌药物。在我们之前对紫杉醇和多西他赛的研究基础上,本工作研究了卡巴他赛并对这三种紫杉烷类进行了比较。通过同源建模、分子对接和分子动力学模拟研究了三种紫杉烷类与各种β-微管蛋白亚型的结合相互作用。结果表明,多西他赛对βI-微管蛋白(-29.5 kcal/mol)和紫杉醇对βIIa-微管蛋白(-25.5 kcal/mol)的作用远强于它们对βIII-微管蛋白(-17.8 kcal/mol 和-8.6 kcal/mol)的作用。然而,卡巴他赛对βIII-微管蛋白(-23.0 kcal/mol)的作用与对βI-微管蛋白(-24.0 kcal/mol)和βIIa-微管蛋白(-25.9 kcal/mol)的作用相当,这与βIII-微管蛋白过表达增加紫杉醇和多西他赛耐药性的事实一致,但对卡巴他赛影响不大。这一理论研究支持将卡巴他赛用于对紫杉醇和多西他赛作用产生耐药性的患者。

相似文献

1
Binding modes of cabazitaxel with the different human β-tubulin isotypes: DFT and MD studies.与不同人β-微管蛋白亚型结合的卡巴他赛结合模式:DFT 和 MD 研究。
J Mol Model. 2020 May 30;26(6):162. doi: 10.1007/s00894-020-04400-w.
2
βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.与多西他赛相比,βIII微管蛋白可增强卡巴他赛的疗效。
Cancer Chemother Pharmacol. 2017 Jul;80(1):151-164. doi: 10.1007/s00280-017-3345-2. Epub 2017 May 31.
3
Computational analysis of drug resistance of taxanes bound to human β-tubulin mutant (D26E).紫杉烷类药物与人类β-微管蛋白突变体(D26E)结合的耐药性的计算分析。
J Mol Graph Model. 2023 Sep;123:108503. doi: 10.1016/j.jmgm.2023.108503. Epub 2023 May 15.
4
Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.在乳腺癌中涉及βI-、βIIA-或βIVB-微管蛋白亚型的新型突变,其功能与βIII-微管蛋白相似。
Protoplasma. 2017 May;254(3):1163-1173. doi: 10.1007/s00709-016-1060-1. Epub 2016 Dec 9.
5
Elucidating the mechanism of action of the clinically approved taxanes: a comprehensive comparison of local and allosteric effects.阐明临床批准的紫杉烷类药物的作用机制:局部效应与变构效应的全面比较
Chem Biol Drug Des. 2015 Nov;86(5):1253-66. doi: 10.1111/cbdd.12595. Epub 2015 Jul 14.
6
Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.分子动力学模拟和自由能景观方法用于探究导致癌细胞对紫杉醇耐药的βI-微管蛋白L215H、L217R和L225M突变
Biochem Biophys Res Commun. 2016 Aug 5;476(4):273-279. doi: 10.1016/j.bbrc.2016.05.112. Epub 2016 May 24.
7
Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.所选多西他赛耐药的MCF-7乳腺癌细胞中对紫杉烷获得性耐药的多种潜在机制。
BMC Cancer. 2014 Jan 22;14:37. doi: 10.1186/1471-2407-14-37.
8
Mechanisms of resistance to cabazitaxel.对卡巴他赛的耐药机制。
Mol Cancer Ther. 2015 Jan;14(1):193-201. doi: 10.1158/1535-7163.MCT-14-0155. Epub 2014 Nov 21.
9
Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.具有高效诱导微管蛋白组装能力的紫杉烷类药物可克服肿瘤细胞耐药性。
Bioorg Med Chem. 2014 Sep 15;22(18):5078-90. doi: 10.1016/j.bmc.2014.05.048. Epub 2014 Jun 19.
10
Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer Cells.新型紫杉烷类化合物的设计与测试,以探究紫杉烷类与微管结合并对癌细胞产生细胞毒性的高度复杂机制。
PLoS One. 2015 Jun 8;10(6):e0129168. doi: 10.1371/journal.pone.0129168. eCollection 2015.

引用本文的文献

1
Multiscale analysis and optimal glioma therapeutic candidate discovery using the CANDO platform.使用CANDO平台进行多尺度分析和最佳胶质瘤治疗候选物发现。
bioRxiv. 2025 May 23:2025.05.19.654757. doi: 10.1101/2025.05.19.654757.
2
Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach.探索吡咯并稠合杂环作为有前景的抗癌剂:一种综合的合成、生物学和计算方法。
Pharmaceuticals (Basel). 2023 Jun 11;16(6):865. doi: 10.3390/ph16060865.
3
Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin.
载榄香烯和紫杉醇的转铁蛋白修饰仿生脂质体主动靶向治疗原位脑胶质瘤。
J Nanobiotechnology. 2021 Sep 26;19(1):289. doi: 10.1186/s12951-021-01048-3.
4
Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin.微管相关蛋白 tau 作为生物标志物在具有上皮来源的癌症中对紫杉烷类治疗的反应和增加疗效的双重作用。
Pharmacol Res. 2021 Jun;168:105585. doi: 10.1016/j.phrs.2021.105585. Epub 2021 Mar 30.
5
Mechanisms of Taxane Resistance.紫杉烷耐药机制。
Cancers (Basel). 2020 Nov 10;12(11):3323. doi: 10.3390/cancers12113323.